InSights Hub

News

Showing 201 to 210 of 283 (Page 21)

Guidelines Spotlight Acne Vulgaris

Management of Acne – Guidelines Spotlight

Acne is one of the most prevalent skin conditions treated by dermatologists.  It is characterized as a chronic, inflammatory disease that can significantly impact the lives of patients. In January 2024, the American Academy of Dermatology (AAD) released Guidelines of Care for the Management of Acne Vulgaris to offer standardized, evidence-based recommendations for the treatment […]

Read More
Guidelines Spotlight ACCAHA Hypertrophic Cardiomyopathy (HCM)

New Hypertrophic Cardiomyopathy Guidelines 2024 – What’s Changed and Key Takeaways

A focused update to the ACC/AHA Hypertrophic Cardiomyopathy (HCM) Clinical Guidelines was released today. The new guidelines update the previous 2020 guidelines for Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. Today we’ll take a look at what’s changed, as well as some of the key takeaways from the new 2024 HCM Guidelines. Before we […]

Read More
Mechanical Ventilation - Guidelines Rundown

Mechanical Ventilation – Guidelines Rundown

Our Guidelines Rundown Series continues with a new article focusing on mechanical ventilation. There are many current guidelines on mechanical ventilation, published by over a half dozen different medical societies. These guidelines both cover mechanical ventilation in a broad sense, as well as in specific situations, such as prevention of VAP. Today we’re going to […]

Read More
Cardiology Guidelines + Journal Rundown Cardiology

Cardiology – Guidelines+ Journals Rundown (May 2024)

In this post, we will be taking a closer look at some of the most popular cardiology-related articles that have been published during the months of April and May 2024. Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association Stress […]

Read More
Treating Major Depressive Disorder - Guidelines Evolution

Treating Major Depressive Disorder – What’s Changed

In honor of Mental Health Awareness Month 2024, we will be examining the most recent guidelines on major depressive disorder (MDD). Surprisingly, there are not many US-based guidelines for the management of MDD. The most recent guideline was actually published by the Department of Veterans Affairs and the Department of Defense (VA/DoD) in April 2022. […]

Read More
Digestive Disease Week 2024

DDW Conference Preview – IBD at Digestive Disease Week® 2024

Digestive Disease Week® (DDW) will be held May 18-21, 2024, in Washington, DC. This annual event serves as the leading gathering for gastroenterologists, researchers, and industry professionals dedicated to improving outcomes for patients affected by gastrointestinal diseases.   Before proceeding, we strongly encourage you to register for the event by clicking here. This will allow you […]

Read More
ASCO Conference Preview 2024

ASCO24 Conference Preview – Lung Cancer at the ASCO Annual Meeting 2024

As we approach the kickoff of the 2024 ASCO Annual Meeting, we are taking a look at some of the “can’t miss” sessions, symposiums, presentations and more, specific to lung cancer. This includes Non-Small-Cell Lung Cancer (NSCLC) and Small-Cell Lung Cancer (SCLC), and both early and metastatic. Before we dive in, if you are an […]

Read More

What’s New in Infectious Diseases So Far Through April 2024 – Guidelines Rundown

Today, we will be providing an overview of the latest developments in the field of Infectious Diseases up to April 2024. This includes new medications, new guidelines, and noteworthy research and journal articles that have been published in the first four months of the year. Recent Infectious Diseases-Related Clinical Guidelines Recent Infectious Disease-Related FDA Medication […]

Read More

Upcoming FDA Decisions – May 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug or device applications. Below, you will find a list of drugs and devices, […]

Read More
« Back to InSights Hub